Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Aspirin for Myocardial Injury Post Non-cardiac Surgery
NCT02291419Phase 4Terminated
- Sponsor
- Cleveland Clinic
- Start
- Jul 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ticagrelor in Myocardial injury (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Major Adverse Cardiovascular Events at 6 months. Started Jul 2015; status: terminated.
02
Drugs
ticagrelor
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on NCT02291419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291419.